Ki-67, p53, and bcl-2 expression of serrated adenomas of the colon

被引:63
作者
Kang, M
Mitomi, H
Sada, M
Tokumitsu, Y
Takahashi, Y
Igarashi, M
Katsumata, T
Okayasu, I
机构
[1] KITASATO UNIV,SCH MED,DEPT PATHOL,SAGAMIHARA,KANAGAWA 228,JAPAN
[2] KITASATO UNIV,SCH MED,DEPT GASTROENTEROL,SAGAMIHARA,KANAGAWA 228,JAPAN
关键词
serrated adenoma; cell proliferation; Ki-67; p53; Bcl-2;
D O I
10.1097/00000478-199704000-00007
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To investigate epithelial cell proliferation and oncoprotein expression of the serrated adenoma, a term that has been used synonymously with mixed hyperplastic and adenomatous polyp, immunohistochemical staining using polyclonal antibodies against Ki-67 and p53, and a Bcl-2 monoclonal antibody, was performed and the results compared with those in hyperplastic polyps and tubular adenomas. A total of 20 serrated adenomas all characterized by a serrated glandular pattern, contained immature goblet cells, upper-crypt zone mitotic figures, and a few nucleoli within the epithelial cells. Twenty hyperplastic polyps and 20 tubular adenomas (all with low-grade dysplasia) were examined, and lesions that contained separate areas of hyperplastic and adenomatous glands were excluded. The Ki-67-positive rate in the middle zone of the crypts in serrated adenomas was significantly higher than in hyperplastic polyps but lower than in tubular adenomas; a similar tendency was also noted for the upper zone. Both serrated adenomas and hyperplastic polyps demonstrated Bcl-2-positive reactivity that was essentially limited to the lower crypt zone, while in contrast, involvement in tubular adenomas often extended to the middle zone. No p53 overexpression was found in any category. These results suggest;hat serrated adenomas may be committed to independent growth.
引用
收藏
页码:417 / 423
页数:7
相关论文
共 21 条
[1]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[2]  
BASS IO, 1994, J PATHOL, V172, P5
[3]  
BRONNER MP, 1995, AM J PATHOL, V146, P20
[4]   MONOCLONAL-ANTIBODY KI-67 - ITS USE IN HISTOPATHOLOGY [J].
BROWN, DC ;
GATTER, KC .
HISTOPATHOLOGY, 1990, 17 (06) :489-503
[5]  
CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7437
[6]  
ENTERLINE HT, 1976, CURR TOP PATHOL, V63, P97
[7]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[8]  
GEBBERS JO, 1986, VIRCHOWS ARCH A, V410, P189
[9]  
GERDES J, 1984, J IMMUNOL, V133, P1710
[10]  
GOLDMAN H, 1970, ARCH PATHOL, V89, P349